Check Claims Before You Publish

Representative high-impact works (coauthored)

• PPARγ signaling and metabolism: the good, the bad and the future — Nature Medicine 2013; broad review synthesising PPARγ translational biology; Liddle is middle author and paper has high citation impact PPARγ review (Nat Med)
• Vitamin D receptor and pancreatic stromal reprogramming — Cell 2014; translational preclinical study; Liddle appears among multidisciplinary collaborators VDR stromal reprogramming (Cell)
• REV-ERB regulation of circadian behaviour and metabolism — Nature 2012; key paper on nuclear receptor clock regulation with broad implications REV-ERB circadian regulation (Nature)

What the evidence says (concise)

1. High productivity and impact: the OpenAlex summary reports ~248 works and ~21.7k total citations with an h-index ≈72 — consistent with a sustained, influential publication record across >30 years (see per‑year counts visualization above).
2. Topical breadth: most work clusters in nuclear receptors, metabolism, liver disease (NASH), endocrine signalling and gene regulation — many coauthored with prominent labs (Salk Institute, Westmead, University of Sydney) indicating collaborative, translational focus VDR/SMAD hepatic fibrosis (Cell).
3. Translational emphasis: contributions include clinical/phenotypic studies (e.g., NASH and CYP biology) and mechanistic molecular studies — good balance of human and mechanistic data in coauthored outputs CYP2E1 in NASH (Hepatology).

Limitations & blindspots (critical)

• Coauthorship vs leadership: many highly cited outputs are multi‑author; position varies (middle author on several top papers), so influence must be interpreted as collaborative rather than always PI‑led.
• Metrics caveat: citation counts and h‑index reflect visibility and collaboration networks and can overweight review articles and large consortium works — these are useful but not sole evidence of technical novelty or unique intellectual leadership.
• Public dataset transparency: OpenAlex provides metadata but not raw experimental data; evaluating experimental rigor requires paper‑level reading (methods, sample sizes, blinding), beyond metadata metrics alone.

Practical takeaways & next steps

1. Overall assessment: established, highly productive biomedical scientist with substantial collaborative contributions to nuclear receptor biology, metabolism and liver disease.
2. To evaluate scientific rigor in detail: read representative primary research papers (methods, sample sizes, statistics, raw data availability), and audit specific experiments for reproducibility.
3. If you want, run a focused paper‑level critique of one or two of Liddle's primary research articles (I can generate a methods/statistics checklist and flag likely weaknesses).

OpenAlex author summary (author id A5049828619) provided counts_by_year, works_count=248, cited_by_count≈21754 and h_index≈72 used to build the visual timeline above.